Form 4: Waters Director Ornskov Boosts Stake with Stock Grants

Waters Corp. Director Flemming Ornskov acquired 336 restricted common shares and options for 57 shares, vesting in February 2027.

Summary

• Director Flemming Ornskov acquired 336 shares of Waters Corp. common stock on February 25, 2026.
• These 336 shares are restricted and will fully vest on February 9, 2027.
• Ornskov also acquired stock options to purchase 57 shares of common stock on February 25, 2026.
• The stock options have an exercise price of $319.44 per share.
• These 57 stock options will vest and become exercisable on February 9, 2027, and will expire on February 25, 2036.
• Following these transactions, Ornskov directly beneficially owns 5,271 shares of common stock and 57 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating continued insider alignment and standard compensation practices, which generally supports investor confidence.

Positives

• An insider, Director Flemming Ornskov, increased his beneficial ownership in Waters Corp. through new grants of restricted stock and stock options.
• The acquisition of 336 restricted common shares and options for 57 shares demonstrates continued alignment of management interests with shareholders.

Negatives

• NA

Risks

• NA

Future Outlook

The vesting schedule for the restricted stock and stock options indicates a future alignment of Director Ornskov's interests with the company's long-term performance, with full vesting scheduled for February 9, 2027.

Management Comments

• NA

Industry Context

StockSavvy.ai notes that insider grants of equity, such as restricted stock and stock options, are a common practice in the life sciences and analytical instruments industry, aligning executive incentives with shareholder value creation. This type of compensation is standard across peers like Agilent Technologies and Thermo Fisher Scientific, reinforcing long-term commitment.

Comparison to Industry Standards

• The grant of restricted stock and stock options to a director is a standard compensation practice in the U.S. market, comparable to practices at companies like Danaher Corporation or PerkinElmer, which also utilize equity-based incentives for their board members.
• The vesting period until February 9, 2027, for both the restricted stock and options is a typical multi-year vesting schedule designed to encourage long-term commitment and performance, consistent with corporate governance best practices seen in the S&P 500.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with long-term shareholder value through equity grants.

Next Steps

• The 336 restricted common shares will vest on February 9, 2027.
• The 57 stock options will become exercisable on February 9, 2027.
• The 57 stock options will expire on February 25, 2036.

Key Dates

Recommendation

This Form 4 filing reports routine equity compensation grants to a director, which is a standard practice for aligning insider interests with long-term company performance. It does not contain information that would fundamentally alter the investment thesis for Waters Corp., thus a 'hold' recommendation is appropriate as it reinforces existing expectations without providing new catalysts for significant price movement.

Keywords

Waters Corp, WAT, Flemming Ornskov, Director, Insider Transaction, Form 4, Stock Grant, Restricted Stock, Stock Options, Beneficial Ownership